Technical workshop on cellular mediated immunity to human papillomavirus: prospects for vaccine development. Geneva 18-19 April 2005
Persistent infection of cervical epithelium with high-risk types of human papillomavirus (HPV) can lead to cervical intraepithelial neoplasia (CIN) and ultimately to invasive cervical cancer. Vaccines to render the ridal infections innocuous or to eliminate established infections are under clinical evaluation. A group of experts met on April 18-19, in Geneva, to review progress in the field and draw conclusions for the future assessment of prophylactic and therapeutic vaccines in development. The meeting report will document progress in clinical trials and future research approaches. This report is available online only.
Size: 900 KB